Focus on Infectious Disease
  • Saved

COVID-19 Vaccine Regulatory Strategy Evolving With The Pandemic

COVID-19 Vaccine Regulatory Strategy Evolving With The Pandemic

Source : 'The Pink Sheet'

Reported decisions by AstraZeneca PLC and Novavax, Inc. to alter development and launch strategies for their coronavirus vaccines may not necessarily affect the US campaign against...

  • Saved

Pfizer/BioNTech’s COVID-19 Vaccine Moves Into Adolescents; Adcomm To Weigh Broader Pediatric Issues

Pfizer/BioNTech’s COVID-19 Vaccine Moves Into Adolescents; Adcomm To Weigh Broader Pediatric Issues

Source : 'The Pink Sheet'

The US Food and Drug Administration expanded the authorized use of Pfizer Inc. and BioNTech SE’s COVID-19 vaccine to adolescents on 10 May, just hours after...

  • Saved

UK Steps Up Search For Vaccines Against ‘Variants Of Concern’

UK Steps Up Search For Vaccines Against ‘Variants Of Concern’

Source : 'The Pink Sheet'

The UK has announced plans for the development of new COVID-19 vaccines that include running human challenge trials using a new variant of the coronavirus and investing in new testing...

  • Saved

US Gov't Plans To Control COVID Vaccine Distribution At Least Through 2022; Already Authorized Products Have Booster Advantage

US Gov't Plans To Control COVID Vaccine Distribution At Least Through 2022; Already Authorized Products Have Booster Advantage

Source : 'The Pink Sheet'

The US government plans to purchase and supply the next round of COVID-19 vaccines to Americans free of charge if boosters are needed in 2022, David Kessler, the Chief Science...

  • Saved

Pfizer’s Outlier Quarter, At Both Extremes

Pfizer’s Outlier Quarter, At Both Extremes

Source : 'The Pink Sheet'

When a product that didn’t exist even as a concept 18 months ago is suddenly going to bring in $26bn in annual revenue, investors can be expected to have some...